https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Cell-MS.jpg

Orthobiologics Market Analysis, Size, Trends | South Korea | 2020-2026 | MedSuite

  • Year: 2020
  • Scope: 2016-2026
  • Region: South Korea
  • Pages: 293
  • Published Date: 02/11/2020
  • Type: MedSuite

By 2020, the South Korean orthobiologics market size was valued at $141.6 million, with over 200,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.6% to reach $181.5 million in 2026.

Throughout this medical market research, we analyzed 16 orthobiologics companies across South Korea and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

While this MedSuite report contains all of the South Korean Orthopedic Biomaterials market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2026, and Historical Data to 2016
  • Market Drivers & Limiters for Each Orthopedic Biomaterials Device market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Orthopedic Biomaterials Procedure Volumes
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors
  • Related Press Releases from Top Competitors

Market Value and Industry Trends

A lack of product differentiation across similar injection cycle products has led to commoditization, which has stifled innovation and the further development of new products. Similar to Japan, the prices of HA viscosupplementation products in South Korea have drastically decreased since their introduction and are among the lowest in the world.

South Korea Orthobiologics Market Size by Segment, 2016-2026

Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. By 2020, approximately 15% of South Koreans were aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65.

The bone graft substitute market in South Korea is primarily dominated by allografts and DBM allografts. A major driver to their usage is that they are both easily accessible, as they are distributed by several companies and bone banks.

Competitive Analysis

South Korea Orthopedic Biomaterials Market Leaders

By 2020, the leading competitor in the South Korean orthopedic biomaterials market was Cellumed, which was attributed to its leading position in the orthopedic bone graft substitute market. The company held the second-leading position in the allograft and DBM allograft markets.

JunYoung Medical was the second-leading competitor, which was attributed to its second-leading position in the orthopedic bone graft substitute market. The company held the leading position in the allograft market and the third-leading position in the DBM allograft market. JunYoung Medical does not manufacture its own products, but instead distributes allograft and DBM allograft products for LifeNet Health.

Other notable competitors included, but were not limited to, Shin Poong, HansBiomed, LG Chem, and DongKook. The presence of local companies in South Korea is strong, and only a few international companies have been able to secure notable share in the orthopedic bone graft substitute market.

Segments Covered

Click on each title to view more detailed market segmentation.

  • Procedure Volumes for Orthopedic Biomaterials DevicesMedPro – The complete procedural analysis for each segment of the South Korean Orthopedic Biomaterials market.
  • Orthopedic Bone Graft Substitute Market – MedCore – This market is segmented by Material Type, including Allograft, Demineralized Bone Matrix Allograft, and Synthetic. Each of these material types are segmented by Indication, including Spine, Trauma, Large Joint Reconstruction, Foot Reconstruction, Craniomaxillofacial, and Oncology.
  • Hyaluronic Acid Viscosupplementation Market – MedCore – This market is categorized by Treatment Type, including Single-Injection, Three-Injection and Five-Injection.

Detailed Market Segmentation


DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

TABLE OF CONTENTS FOR THE SOUTH KOREAN ORTHOPEDIC BIOMATERIALS MARKET

TABLE OF CONTENTS I
LIST OF FIGURES VIII
LIST OF CHARTS XV
EXECUTIVE SUMMARY 1
SOUTH KOREAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 5
MARKET DEVELOPMENTS 6
PROCEDURE NUMBERS 7
MARKETS INCLUDED 8
KEY REPORT UPDATES 10
VERSION HISTORY 10
RESEARCH METHODOLOGY 11
Step 1: Project Initiation & Team Selection 11
Step 2: Prepare Data Systems and Perform Secondary Research 14
Step 3: Preparation for Interviews & Questionnaire Design 16
Step 4: Performing Primary Research 17
Step 5: Research Analysis: Establishing Baseline Estimates 19
Step 6: Market Forecast and Analysis 20
Step 7: Identify Strategic Opportunities 22
Step 8: Final Review and Market Release 23
Step 9: Customer Feedback and Market Monitoring 24

PRODUCT ASSESSMENT

2.1 INTRODUCTION 25
2.2 PRODUCT PORTFOLIOS 25
2.2.1 Bone Graft Substitutes 26
2.2.2 Growth Factors 32
2.2.2.1 Other Products 35
2.2.3 Hyaluronic Acid Viscosupplementation (HAV) 37
2.3 REGULATORY ISSUES AND RECALLS 40
2.3.1 Bone Graft Substitutes 40
2.3.1.1 Allografts 40
2.3.1.1.1 MTF 40
2.3.1.2 DBM 40
2.3.1.2.1 AlloSource 40
2.3.1.2.2 SeaSpine 41
2.3.1.2.3 RTI Surgical 41
2.3.1.3 Synthetics 41
2.3.1.3.1 Abyrx 41
2.3.1.3.2 Zimmer Biomet 42
2.3.2 Growth Factors 42
2.3.2.1.1 Medtronic 42
2.3.3 Hyaluronic Acid Viscosupplementation 43
2.3.3.1 Three-injection 43
2.3.3.1.1 Ferring Pharmaceuticals 43
2.4 CLINICAL TRIALS 44
2.4.1 Bone Graft Substitutes 44
2.4.1.1 Allografts 44
2.4.1.1.1 Providence Medical Technology 44
2.4.1.1.2 The University of Texas Health Science 44
2.4.1.1.3 University of Winchester 45
2.4.1.2 BDM 45
2.4.1.2.1 K2M 45
2.4.1.2.2 Zimmer Biomet 46
2.4.1.3 Synthetics 46
2.4.1.3.1 Baxter 46
2.4.1.3.2 Bonesupport 47
2.4.1.3.3 DePuy Synthes 47
2.4.1.3.4 NuVasive 49
2.4.1.3.5 RTI surgical 49
2.4.1.3.6 Sunstar GUIDOR 50
2.4.1.4 Other materials and comparison 51
2.4.1.4.1 Seoul National University Hospital. 51
2.4.1.4.2 Sewon Cellontech 51
2.4.1.4.3 SurgaColl Technologies Limited 52
2.4.1.4.4 University of Colorado 52
2.4.1.4.5 University of Padova 53
2.4.2 Growth Factors 53
2.4.2.1.1 Bioventus 53
2.4.2.1.2 Cerapedics 54
2.4.2.1.3 CGBio 54
2.4.2.1.4 Isto 55
2.4.2.1.5 Medtronic 55
2.4.2.1.6 NuVasive 57
2.4.2.1.7 Wright 57
2.4.2.1.8 Others 58
2.4.3 Hyaluronic Acid Viscosupplementation 59
2.4.3.1.1 Anika Therapeutics 59
2.4.3.1.2 Bioventus 60
2.4.3.1.3 Cairo University 61
2.4.3.1.4 Ferring Pharmaceuticals 61
2.4.3.1.5 Federal University of Minas Gerais 62
2.4.3.1.6 Fidia Pharma USA Inc. 62
2.4.3.1.7 Istituto Ortopedico Rizzoli 63
2.4.3.1.8 University Hospital 63
2.4.3.1.9 Universidade Nova de Lisboa 64

SOUTH KOREAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW

3.1 INTRODUCTION 65
3.1.1 Bone Graft Substitutes 65
3.1.2 Growth Factors 65
3.1.3 Hyaluronic Acid (HA) Viscosupplementation 66
3.2 CURRENCY EXCHANGE RATE 67
3.3 MARKET OVERVIEW AND TREND ANALYSIS 68
3.4 DRIVERS AND LIMITERS 75
3.4.1 Market Drivers 75
3.4.2 Market Limiters 75
3.5 COMPETITIVE MARKET SHARE ANALYSIS 77
3.6 MERGERS AND ACQUISITIONS 82
3.7 COMPANY PROFILES 84
3.7.1 Anika Therapeutics 84
3.7.2 Bioventus 85
3.7.3 DePuy Synthes 86
3.7.4 Ferring Pharmaceuticals 87
3.7.5 Fidia Pharmaceuticals 88
3.7.6 Genzyme (Sanofi Group) 89
3.7.7 Harvest Technologies (Terumo BCT) 90
3.7.8 Integra LifeSciences 91
3.7.9 Medtronic 92
3.7.10 Musculoskeletal Transplant Foundation (MTF) 94
3.7.11 NuVasive 95
3.7.12 Orthofix 96
3.7.13 RTI Surgical 97
3.7.14 Stryker 98
3.7.15 Vericel Corporation (formerly Aastrom Bioscience) 99
3.7.16 Zimmer Biomet 100
3.8 SWOT ANALYSIS 102
3.8.1 Anika Therapeutics 102
3.8.2 Bioventus 104
3.8.3 DePuy Synthes 106
3.8.4 Ferring Pharmaceuticals 107
3.8.5 Fidia Pharmaceuticals 108
3.8.7 Harvest Technologies (Terumo BCT) 110
3.8.8 Integra LifeSciences 111
3.8.9 Medtronic 112
3.8.10 Musculoskeletal Transplant Foundation (MTF) 113
3.8.11 NuVasive 114
3.8.12 Orthofix 115
3.8.14 Stryker 117
3.8.15 Vericel Corporation (formerly Aastrom Bioscience) 118
3.8.16 Zimmer Biomet 119

PROCEDURE NUMBERS

4.1 INTRODUCTION 121
4.2 PROCEDURES 122
4.2.1 Orthopedic Biomaterial Procedures by Segment 122
4.2.2 Orthopedic Bone Grafting Procedures 124
4.2.2.1 Units per Procedure by Indication 124
4.2.2.2 Orthopedic Bone Grafting Procedures by Material 125
4.2.2.2.1 Autograft Procedures by Indication 127
4.2.2.2.2 Allograft Procedures by Indication 130
4.2.2.2.3 DBM Procedures by Indication 133
4.2.2.2.4 Synthetic Procedures by Indication 136
4.2.2.3 Orthopedic Bone Grafting Procedures by Indication 139
4.2.3 Hyaluronic Acid Viscosupplementation Procedures 142
4.2.3.1 Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle 142

ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET

5.1 INTRODUCTION 144
5.2 MARKET OVERVIEW 145
5.2.1 Orthopedic Bone Graft Substitute Market by Material 145
5.2.2 Orthopedic Bone Graft Substitute Market by Indication 150
5.3 MARKET ANALYSIS AND FORECAST 156
5.3.1 Total Orthopedic Bone Graft Substitute Market 156
5.3.2 Orthopedic Bone Graft Substitute Market by Material 158
5.3.2.1 Allograft Bone Graft Substitute Market 158
5.3.2.1.1 Allograft Bone Graft Substitute Market by Indication 161
5.3.2.2 Demineralized Bone Matrix Allograft Bone Graft Substitute Market 175
5.3.2.2.1 Demineralized Bone Matrix Allograft Bone Graft Substitute Market by Indication 178
5.3.2.3 Synthetic Bone Graft Substitute Market 192
5.3.2.3.1 Synthetic Bone Graft Substitute Market by Indication 195
5.3.3 Orthopedic Bone Graft Substitute Market by Indication 209
5.3.3.1 Spine Bone Graft Substitute Market 209
5.3.3.2 Cervical Spine Bone Graft Substitute Market 212
5.3.3.3 Thoracolumbar Spine Bone Graft Substitute Market 214
5.3.3.4 Trauma Bone Graft Substitute Market 216
5.3.3.5 Non-Union Trauma Bone Graft Substitute Market 219
5.3.3.6 Fresh Fracture Trauma Bone Graft Substitute Market 221
5.3.3.7 Large Joint Reconstruction Bone Graft Substitute Market 223
5.3.3.8 Hip Reconstruction Bone Graft Substitute Market 226
5.3.3.9 Knee Reconstruction Bone Graft Substitute Market 228
5.3.3.10 Foot Reconstruction Bone Graft Substitute Market 230
5.3.3.11 Craniomaxillofacial Bone Graft Substitute Market 233
5.3.3.12 Oncology Bone Graft Substitute Market 236
5.4 DRIVERS AND LIMITERS 239
5.4.1 Market Drivers 239
5.4.2 Market Limiters 239
5.5 COMPETITIVE MARKET SHARE ANALYSIS 241

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

6.1 INTRODUCTION 245
6.1.1 Benefits of Viscosupplementation 246
6.1.2 Synovial Fluid 246
6.2 MARKET OVERVIEW 247
6.3 MARKET ANALYSIS AND FORECAST 253
6.3.1 Total Hyaluronic Acid Viscosupplementation Market 253
6.3.2 Single-Injection Hyaluronic Acid Viscosupplementation Market 256
6.3.3 Three-Injection Hyaluronic Acid Viscosupplementation Market 259
6.3.4 Five-Injection Hyaluronic Acid Viscosupplementation Market 262
6.4 DRIVERS AND LIMITERS 265
6.4.1 Market Drivers 265
6.4.2 Market Limiters 265
6.5 COMPETITIVE MARKET SHARE ANALYSIS 267

APPENDIX: ORTHOPEDIC GROWTH FACTOR MARKET

7.1 INTRODUCTION 271
7.1.1 BMP-2 (Cellumed, CG Bio) 272

ABBREVIATIONS

The Orthopedic Biomaterials Market Report Suite | South Korea | 2020-2026 | MedSuite includes analysis on the following companies currently active in this market:

  • Cellumed
  • CG Bio
  • DePuy Synthes
  • Dong Kwang
  • DongKook
  • Hanmi
  • HansBiomed
  • JunYoung Medical
  • LG Chem
  • Medtronic
  • Sanofi
  • SeaSpine
  • Shin Poong
  • Unimed
  • Wright Medical
  • Zimmer Biomet

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology